Veracyte Current Deferred Revenue from 2010 to 2024
| VCYT Stock | USD 20.65 0.76 3.55% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 2 M | Current Value 2.7 M | Quarterly Volatility 1.3 M |
Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Interest Expense of 14.2 K or Selling General Administrative of 165.5 M, as well as many indicators such as Price To Sales Ratio of 5.26, Dividend Yield of 0.0 or PTB Ratio of 1.82. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
Veracyte | Current Deferred Revenue |
Latest Veracyte's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Veracyte over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Veracyte's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Veracyte Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 1,066,563 | |
| Geometric Mean | 638,108 | |
| Coefficient Of Variation | 122.56 | |
| Mean Deviation | 1,020,160 | |
| Median | 371,000 | |
| Standard Deviation | 1,307,143 | |
| Sample Variance | 1.7T | |
| Range | 4.3M | |
| R-Value | 0.66 | |
| Mean Square Error | 1T | |
| R-Squared | 0.44 | |
| Significance | 0.01 | |
| Slope | 193,172 | |
| Total Sum of Squares | 23.9T |
Veracyte Current Deferred Revenue History
About Veracyte Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Veracyte income statement, its balance sheet, and the statement of cash flows. Veracyte investors use historical funamental indicators, such as Veracyte's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Veracyte investors may use each financial statement separately, they are all related. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Veracyte's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Veracyte Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Veracyte. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2 M | 2.7 M |
Pair Trading with Veracyte
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Veracyte position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veracyte will appreciate offsetting losses from the drop in the long position's value.Moving together with Veracyte Stock
| 0.66 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.65 | PFE | Pfizer Inc Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Veracyte could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Veracyte when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Veracyte - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Veracyte to buy it.
The correlation of Veracyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Veracyte moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Veracyte moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Veracyte can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.